LAKEWOOD, CO, UNITED STATES, April 27, 2026 /EINPresswire.com/ -- The American Animal Hospital Association (AAHA) today ...
Recent research and clinical updates highlight how GLP-1 receptor agonists are transforming diabetes and obesity care, with expanding uses from adolescents with type 2 diabetes to off-label ...
Polycystic Ovary Syndrome (PCOS) is a global concern for 10% – 20% of women in their reproductive age. It can also contribute ...
Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at the Bank of America Securities ...
I’ve read that GLP-1’s are a magic elixir — or a shortcut, even a symptom of cultural decline. Not long after my diagnosis, I ...
A veteran of Pfizer, Sanofi, and Novo Nordisk who built patient access programmes across West Africa argues that the $500 billion medication adherence crisis plaguing American healthcare has already ...
Many challenges of designing and validating pediatric digital health devices are over-looked across developmental stages.
Tandem Diabetes Care (Nasdaq:TNDM) today announced FDA clearance for its automated insulin delivery technology for use in ...
Insulin pump use during hospitalization may improve glycemic outcomes and reduce length of stay for people with diabetes, ...
The FDA has cleared Tandem’s Control-IQ technology as the first ever AID specifically for use in pregnancies complicated by ...
Glucagon-like peptide-1 receptor agonists, known as GLP-1 drugs, are highly effective at helping people lose weight and ...
The FDA cleared an automated insulin delivery system for use by pregnant women with type 1 diabetes, according to an industry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results